Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder
Rebecca McMillan, Rachael L. Sumner, Anna Forsyth, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 99, pp. 109838-109838
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

The role of dissociation in ketamine’s antidepressant effects
Elizabeth D. Ballard, Carlos A. Zarate
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 140
International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators
Rebecca B. Price, Nicholas Kissel, Andrew Baumeister, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 12, pp. 5096-5112
Open Access | Times Cited: 52
Characterizing brain dynamics during ketamine-induced dissociation and subsequent interactions with propofol using human intracranial neurophysiology
Fangyun Tian, Laura D. Lewis, David Zhou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review
Gia Han Le, Sabrina Wong, Sebastian Badulescu, et al.
Journal of Affective Disorders (2024) Vol. 355, pp. 342-354
Closed Access | Times Cited: 9
A qualitative and quantitative account of patient’s experiences of ketamine and its antidepressant properties
Rachael L. Sumner, Emme Chacko, Rebecca McMillan, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 8, pp. 946-961
Closed Access | Times Cited: 53
The anterior cingulate cortex as a key locus of ketamine’s antidepressant action
Laith Alexander, Luke A. Jelen, Mitul A. Mehta, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 531-554
Open Access | Times Cited: 50
A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs
Marco Solmi, Chaomei Chen, Charles Daure, et al.
European Neuropsychopharmacology (2022) Vol. 64, pp. 44-60
Open Access | Times Cited: 31
Imaging synaptic density in depression
Sophie Holmes, Chadi G. Abdallah, Irina Esterlis
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 186-190
Closed Access | Times Cited: 24
Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settings
Claudio Agnorelli, Alessandra Cinti, G. Barillà, et al.
Molecular Psychiatry (2025)
Open Access
An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression
Sherry-Anne Muscat, Glenn Hartelius, Courtenay Crouch, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 28
Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review
Ilya Demchenko, Vanessa K. Tassone, Sidney H. Kennedy, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 21
A unified model of ketamine’s dissociative and psychedelic properties
M. Marguilho, I. Figueiredo, Pedro Castro-Rodrigues
Journal of Psychopharmacology (2022) Vol. 37, Iss. 1, pp. 14-32
Open Access | Times Cited: 20
Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies
Gustavo C. Medeiros, Malcolm Matheson, Isabella Demo, et al.
The Lancet Psychiatry (2023) Vol. 10, Iss. 10, pp. 790-800
Closed Access | Times Cited: 11
Neurobiological biomarkers of response to ketamine
Bashkim Kadriu, Elizabeth D. Ballard, Ioline D. Henter, et al.
Advances in pharmacology (2020), pp. 195-235
Open Access | Times Cited: 29
Transient effects of multi‐infusion ketamine augmentation on treatment‐resistant depressive symptoms in patients with treatment‐resistant bipolar depression – An open‐label three‐week pilot study
Chuanjun Zhuo, Feng Ji, Hongjun Tian, et al.
Brain and Behavior (2020) Vol. 10, Iss. 8
Open Access | Times Cited: 27
Inferring Macroscale Brain Dynamics via Fusion of Simultaneous EEG-fMRI
Marios G. Philiastides, Tao Tu, Paul Sajda
Annual Review of Neuroscience (2021) Vol. 44, Iss. 1, pp. 315-334
Open Access | Times Cited: 26
Efficacy of ketamine for major depressive episodes at 2, 4, and 6-weeks post-treatment: A meta-analysis
Ashley A. Conley, Amber E. Q. Norwood, T Hatvany, et al.
Psychopharmacology (2021) Vol. 238, Iss. 7, pp. 1737-1752
Closed Access | Times Cited: 25
Neuroimaging-Derived Biomarkers of the Antidepressant Effects of Ketamine
Artemis Zavaliangos‐Petropulu, Noor Al‐Sharif, Brandon Taraku, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2022) Vol. 8, Iss. 4, pp. 361-386
Open Access | Times Cited: 17
Review: The use of functional magnetic resonance imaging (fMRI) in clinical trials and experimental research studies for depression
Vasileia Kotoula, Jennifer W. Evans, Claire Punturieri, et al.
Frontiers in Neuroimaging (2023) Vol. 2
Open Access | Times Cited: 10
Spectral Changes of EEG Following a 6-Week Low-Dose Oral Ketamine Treatment in Adults With Major Depressive Disorder and Chronic Suicidality
Toomas Erik Anijärv, Adem Can, Cyrana C. Gallay, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 4, pp. 259-267
Open Access | Times Cited: 9
Preliminary evidence that ketamine alters anterior cingulate resting-state functional connectivity in depressed individuals
Laith Alexander, Peter C.T. Hawkins, Jennifer W. Evans, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Biomarkers of ketamine’s antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology
Alexandra Alario, Mark J. Niciu
Chronic Stress (2021) Vol. 5, pp. 247054702110142-247054702110142
Open Access | Times Cited: 18
Predicting Antidepressant Effects of Ketamine: the Role of the Pregenual Anterior Cingulate Cortex as a Multimodal Neuroimaging Biomarker
Anne Weigand, Matti Gärtner, Milan Scheidegger, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 25, Iss. 12, pp. 1003-1013
Open Access | Times Cited: 13
Neurophysiological evidence that frontoparietal connectivity and GABA-A receptor changes underpin the antidepressant response to ketamine
Rachael L. Sumner, Rebecca McMillan, Anna Forsyth, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Electrophysiological correlates and predictors of the antidepressant response to repeated ketamine infusions in treatment-resistant depression
Sara de la Salle, Jennifer L. Phillips, Pierre Blier, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 115, pp. 110507-110507
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top